Unicycive Therapeutics, Inc.
UNCY
$0.6379
$0.0081.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.77M | 26.14M | 32.35M | 41.78M | 48.93M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.21M | 3.87M | 4.71M | 1.68M | 2.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.37M | 939.00K | 687.00K | 594.00K | 503.00K |
| Total Current Assets | 27.35M | 30.95M | 37.74M | 44.05M | 51.68M |
|
|
|||||
| Total Current Assets | 27.35M | 30.95M | 37.74M | 44.05M | 51.68M |
| Net Property, Plant & Equipment | 601.00K | 720.00K | 833.00K | 647.00K | 709.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 27.95M | 31.67M | 38.57M | 44.70M | 52.39M |
|
|
|||||
| Total Accounts Payable | 1.40M | 1.06M | 548.00K | 1.47M | 1.24M |
| Total Accrued Expenses | 4.14M | 3.56M | 2.99M | 3.12M | 3.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 548.00K | 564.00K | 542.00K | 360.00K | 343.00K |
| Total Finance Division Other Current Liabilities | 10.59M | 18.94M | 6.38M | 8.13M | 25.15M |
| Total Other Current Liabilities | 10.59M | 18.94M | 6.38M | 8.13M | 25.15M |
| Total Current Liabilities | 16.68M | 24.12M | 10.46M | 13.09M | 30.28M |
|
|
|||||
| Total Current Liabilities | 16.68M | 24.12M | 10.46M | 13.09M | 30.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 117.00K | 265.00K | 274.00K | 372.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.68M | 24.24M | 10.72M | 13.36M | 30.65M |
|
|
|||||
| Common Stock & APIC | 111.97M | 108.70M | 107.60M | 60.80M | 61.05M |
| Retained Earnings | -100.70M | -101.27M | -79.75M | -75.65M | -85.50M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 11.27M | 7.43M | 27.85M | -14.85M | -24.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 46.19M | 46.19M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 46.19M | 46.19M |
|
|
|||||
| Total Common Equity | 11.27M | 7.43M | 27.85M | -14.85M | -24.46M |
| Total Preferred Equity | -- | -- | -- | 46.19M | 46.19M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.27M | 7.43M | 27.85M | 31.34M | 21.73M |
|
|
|||||